Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BridgeBio Pharma, Inc.(BBIO) | 6,068,125 | 6,068,125 | 0 | $187.63M | $153.71M | 66.52% | -$33.92M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 1,025,000 | 1,025,000 | 0 | $24.39M | $21.04M | 9.11% | -$3.35M |
| Verona Pharma plc (VRNA)ADS | 1,115,352 | 1,115,352 | 0 | $17.95M | $16.13M | 6.98% | -$1.82M |
| Elevation Oncology Inc (ELEV) | 2,834,910 | 2,834,910 | 0 | $14.54M | $7.65M | 3.31% | -$6.89M |
| Nuvation Bio Inc.CL A(NUVB) | 2,541,009 | 2,541,009 | 0 | $9.25M | $7.42M | 3.21% | -$1.83M |
| COMPASS Pathways plcADS(CMPS) | 964,500 | 964,500 | 0 | $8.02M | $5.83M | 2.52% | -$2.20M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 1,472,331 | 1,472,331 | 0 | $10.38M | $5.51M | 2.38% | -$4.87M |
| Biomea Fusion, Inc.(BMEA) | 798,757 | 798,757 | 0 | $11.94M | $3.59M | 1.56% | -$8.35M |
| Poseida Therapeutics Inc. (PSTX) | 1,043,267 | 1,043,267 | 0 | $3.33M | $3.05M | 1.32% | -$281.7K |
| CalciMedica, Inc.(CALC) | 521,114 | 521,114 | 0 | $2.17M | $2.06M | 0.89% | -$104.2K |
| Marker Therapeutics, Inc.(MRKR) | 314,286 | 314,286 | 0 | $1.35M | $1.71M | 0.74% | +$355.1K |
| Tectonic Therapeutic, Inc.(TECX) | 0 | 84,148 | +84,148 | $0 | $1.39M | 0.60% | +$1.39M |
| Reneo Pharmaceuticals Inc (RPHM) | 886,075 | 886,075 | 0 | $1.47M | $1.34M | 0.58% | -$132.9K |
| Aclaris Therapeutics, Inc.(ACRS) | 434,455 | 434,455 | 0 | $538.7K | $477.9K | 0.21% | -$60.8K |
| Viracta Therapeutics Inc (VIRX) | 288,571 | 288,571 | 0 | $294.3K | $156.9K | 0.07% | -$137.4K |
| Avrobio, Inc. (AVRO) | 1,009,779 | 0 | -1,009,779 | $1.29M | $0 | — | -$1.29M |
| Spruce Biosciences, Inc. (SPRB) | 1,205,511 | 0 | -1,205,511 | $947.5K | $0 | — | -$947.5K |